Cadila Healthcare Ltd. | Mutual Funds
Mutual Funds that own Cadila Healthcare Ltd.
Government Pension Fund - Global (The)
10,898,084
1.07%
-14,744
0.01%
12/31/2017
Franklin India Prima Plus
6,200,000
0.61%
-100,000
2.02%
08/31/2018
Kotak Funds - India Mid Cap
4,559,455
0.45%
2,879,061
1.65%
12/31/2017
Axis Long Term Equity Fund
4,359,463
0.43%
-428,000
0.94%
07/31/2018
Kotak Select Focus Fund
4,300,000
0.42%
374,881
0.8%
07/31/2018
Franklin India Blue Chip Fund
4,200,000
0.41%
-350,000
2.02%
08/31/2018
Vanguard Emerging Markets Stock Index Fund
4,124,420
0.4%
-37,870
0.03%
07/31/2018
UTI - Equity Fund
3,619,650
0.35%
0
1.64%
08/31/2018
Vanguard Total International Stock Index Fund
3,437,546
0.34%
0
0.01%
07/31/2018
SBI Life Equity Fund
3,215,705
0.31%
375,857
1.51%
12/31/2017
| Address |
Zydus Tower
Ahmedabad Gujarat 380015
India
|
|
Employees
|
- |
| Website |
http://www.zyduscadila.com |
| Updated |
09/14/2018 |
| Cadila Healthcare Ltd. operates as a pharmaceutical company, which engages in the discovery, development, and manufacture of healthcare therapies. The firm offer pharmaceutical products including India formulations, Zydus Generics, and medicines offered in other countries. The company was founded by Ramanbhai B. |
